US BANCORP \DE\ - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$3,658
-75.8%
1,570
-53.6%
0.00%
Q1 2024$15,122
+39.3%
3,3830.0%0.00%
Q4 2023$10,859
+34.0%
3,383
+32.3%
0.00%
Q3 2023$8,106
-3.9%
2,557
+50.6%
0.00%
Q2 2023$8,439
+250.0%
1,698
+248.0%
0.00%
Q1 2023$2,411
-88.5%
488
-85.3%
0.00%
Q4 2022$20,946
-61.2%
3,330
-32.4%
0.00%
Q3 2022$54,000
-14.3%
4,923
-10.1%
0.00%
Q2 2022$63,000
+80.0%
5,474
+41.9%
0.00%
Q1 2022$35,000
-16.7%
3,858
+35.5%
0.00%
Q4 2021$42,000
+200.0%
2,848
+420.7%
0.00%
Q3 2021$14,000
-94.8%
547
-94.7%
0.00%
-100.0%
Q2 2021$271,000
-26.0%
10,410
+0.4%
0.00%0.0%
Q1 2021$366,000
+5128.6%
10,368
+3390.9%
0.00%
Q4 2020$7,000
+250.0%
297
+494.0%
0.00%
Q3 2020$2,000
-33.3%
50
-31.5%
0.00%
Q2 2020$3,000
+200.0%
73
+46.0%
0.00%
Q1 2020$1,0000.0%500.0%0.00%
Q4 2019$1,0000.0%500.0%0.00%
Q3 2019$1,000500.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders